|
1
|
venBio Partners
San Francisco,
California
|
$108M
|
–
|
–
|
–
|
|
|
2
|
Fidelity Investments
Boston,
Massachusetts
|
$83.9M
|
+$702K
|
+49,991
|
+0.7%
|
|
|
3
|
Redmile Group
San Francisco,
California
|
$48.2M
|
+$9.37M
|
+667,245
|
+18%
|
|
|
4
|
Vivo Capital
Palo Alto,
California
|
$47.1M
|
–
|
–
|
–
|
|
|
5
|
Cormorant Asset Management
Boston,
Massachusetts
|
$35M
|
–
|
–
|
–
|
|
|
6
|
|
$30.3M
|
-$5.3M
|
-377,030
|
-12%
|
|
|
7
|
Vestal Point Capital
New York
|
$29.1M
|
+$13.4M
|
+955,000
|
+58%
|
|
|
8
|
|
$24.8M
|
-$190K
|
-13,532
|
-0.6%
|
|
|
9
|
Vanguard Group
Malvern,
Pennsylvania
|
$17.5M
|
+$900K
|
+64,055
|
+4%
|
|
|
10
|
MPM BioImpact
Boston,
Massachusetts
|
$14.1M
|
+$52.1K
|
+3,712
|
+0.3%
|
|
|
11
|
Citadel Advisors
Miami,
Florida
|
$13.8M
|
+$29.6K
|
+2,108
|
+0.2%
|
|
|
12
|
Geode Capital Management
Boston,
Massachusetts
|
$6.74M
|
+$276K
|
+19,680
|
+3%
|
|
|
13
|
State Street
Boston,
Massachusetts
|
$6.18M
|
+$736K
|
+52,371
|
+10%
|
|
|
14
|
|
$3.83M
|
-$992K
|
-70,656
|
-17%
|
|
|
15
|
Northern Trust
Chicago,
Illinois
|
$2.73M
|
+$19.3K
|
+1,372
|
+0.6%
|
|
|
16
|
Renaissance Technologies
New York
|
$2.61M
|
-$511K
|
-36,400
|
-13%
|
|
|
17
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$2.6M
|
-$4.36M
|
-310,474
|
-57%
|
|
|
18
|
Charles Schwab
San Francisco,
California
|
$2.34M
|
+$22.4K
|
+1,595
|
+0.8%
|
|
|
19
|
Federated Hermes
Pittsburgh,
Pennsylvania
|
$2.25M
|
+$67.8K
|
+4,826
|
+2%
|
|
|
20
|
Adage Capital Partners
Boston,
Massachusetts
|
$1.78M
|
–
|
–
|
–
|
|
|
21
|
|
$1.75M
|
+$931K
|
+66,259
|
+73%
|
|
|
22
|
Wellington Management Group
Boston,
Massachusetts
|
$1.42M
|
+$651K
|
+46,349
|
+57%
|
|
|
23
|
Marshall Wace
London,
United Kingdom
|
$1.36M
|
+$1.54M
|
+109,977
|
+951%
|
|
|
24
|
|
$1.19M
|
+$1.49M
|
+106,356
|
New
|
|
|
25
|
Nuveen
Charlotte,
North Carolina
|
$1.18M
|
–
|
–
|
–
|
|
